Status:
UNKNOWN
The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Disseminated Intravascular Coagulation
Eligibility:
All Genders
18-94 years
Brief Summary
The project was undertaking by Qilu Hospital of Shandong University, aiming to evaluate diagnostic performance of hemostatic biomarkers in disseminated intravascular coagulation.
Detailed Description
Disseminated intravascular coagulation (DIC) is a life-threatening condition with high mortality, necessitating timely and accurate diagnosis for effective management. However, current diagnostic syst...
Eligibility Criteria
Inclusion
- 18 years old, non-perinatal period, a hospitalization length of≥3 days.
Exclusion
- primary hematologic diseases, decompensated liver cirrhosis, chemotherapy history.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
462 Patients enrolled
Trial Details
Trial ID
NCT05995093
Start Date
December 1 2022
End Date
June 30 2024
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miao Xu
Ji'nan, Shandong, China, 250000